Ziehe das Cover mit der Maus um es neu zu Positionieren
Familienmitglieder
Keine Mitglieder gefunden
Über Uns
At LIQOMICS, we specialize in advanced minimal residual disease (MRD) testing using liquid biopsy techniques. Our ctDNA-based assays offer unparalleled sensitivity, enabling early detection of residual cancer cells post-treatment. This approach facilitates timely interventions and personalized treatment strategies. Trust LIQOMICS for precise MRD monitoring to enhance patient outcomes.
Beschneide deinen Avatar
